Abstract
Plasma chitotriosidase activity (ChT) was previously proposed to quantify severity of sepsis. In a complex surgical case, with prolonged sepsis and consistently high ChT, we found that the least increased values occurred in stages of extreme illness, with profound hypocholesterolemia. ChT needs better characterization before becoming a reliable biomarker of septic evolution.
| Original language | English |
|---|---|
| Pages (from-to) | 273-276 |
| Number of pages | 4 |
| Journal | Current Medical Research and Opinion |
| Volume | 32 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2016 |
All Science Journal Classification (ASJC) codes
- General Medicine
Keywords
- Aged
- Biomarkers
- Critical illness
- Hexosaminidases
- Humans
- Hypocholesterolemia
- Intensive care
- Male
- Medicine (all)
- Monitoring
- Plasma chitotriosidase
- Sepsis
Fingerprint
Dive into the research topics of 'Clinical use of plasma chitotriosidase in severe sepsis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver